Clinical Trials Logo

Clinical Trial Summary

The rationale of this study in UGIB patients is to assess whether the prediction of mortality and morbidity using AIMS65 score improves when used in combination with RDW in the emergency department setting.


Clinical Trial Description

UGIB is a ticking time-bomb and emergency physicians are challenged to accurately assess risk, and aggressively manage patients with gastrointestinal bleeding within the stipulated time in the confines of emergency department. If not managed properly, it is associated with high mortality. Various clinical prediction scores help in risk stratifying such patients. Among the scores, AIMS65 score is the easy to use score and has good mortality predictive accuracy. RDW, once thought as marker of chronic blood loss has recently been identified as a good prognostic indicator as well as good predictor of mortality in conditions where there is acute blood loss. Both AIMS65 score and RDW value have been used separately as a predictor of morbidity and mortality in patients with UGIB. But there are not much studies so far evaluating their combined role as marker of predicting mortality as well as high risk among UGIB patients. Hence there is a need for a study to know the predictive value of combination of AIMS6S score and RDW in patients presenting to ED with symptoms of UGIB not been much studies comparing the relationship between RDW and upper GI bleed. The rationale of this study in UGIB patients is to assess whether the prediction of mortality and morbidity using AIMS65 score improves when used in combination with RDW in the emergency department setting. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04825977
Study type Observational
Source Jubilee Mission Medical College and Research Institute
Contact
Status Completed
Phase
Start date August 1, 2018
Completion date October 31, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02537353 - Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip Phase 4
Recruiting NCT03624517 - Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices Phase 4
Suspended NCT03337256 - Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy N/A
Completed NCT04472364 - HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding N/A
Completed NCT05563714 - Anticoagulation With Enhanced Gastrointestinal Safety N/A
Recruiting NCT00414713 - Transfusion Requirements in Gastrointestinal (GI) Bleeding Phase 4
Completed NCT03680950 - Efficacy Test of Real-Time Upper Gastrointestinal Monitoring System N/A
Completed NCT05085405 - Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial N/A
Recruiting NCT06077916 - Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy N/A
Recruiting NCT04902248 - OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding N/A
Completed NCT02446678 - Use of PillCam ESO2 in Triaging Patients Present With Upper GIB N/A
Completed NCT05631639 - Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study N/A
Completed NCT02978391 - UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD N/A
Completed NCT00045799 - Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill Phase 3
Recruiting NCT03090945 - Pediatric Acute Gastrointestinal Bleeding Registry
Recruiting NCT06192355 - Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding. N/A
Recruiting NCT06297954 - Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding Phase 3
Recruiting NCT03785080 - Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients N/A
Completed NCT03667703 - Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease Phase 4
Terminated NCT02017379 - Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed. N/A